Treatment of snoring using a non-invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial.

Abstract

OBJECTIVES:

The aim of this study was to assess safety and efficacy of a non-invasive 2940 nm Er:YAG treatment with SMOOTH mode in reducing snoring in adult patients and to compare its efficacy and safety to sham treatment in a randomized controlled trial setting.  METHODS: 40 primary snoring patients (≥ 18 year, AHI < 15e/h, BMI ≤ 30) were randomized to receive either 3 sessions NightLase or sham laser treatment. The main outcome measures were Snore Outcomes Survey (SOS), the Spouse/Bed Partner Survey (SBPS), a visual analogue snoring scale (bed partner) and a visual analogue pain scale.

RESULTS:

NightLase was well tolerated, no local anaesthesia was required (mean VAS pain score in NightLase group = 3.0 ± 1.7). No complications occurred. SOS, SBPS and VAS snoring scores improved in the NightLase group (33.7 ± 14.1 to 56.2 ± 16.1) (35.0 ± 17.1 to 61.5 ± 16.4) and (7.9 ± 2.0 to 4.7 ± 2.8) while no changing in the sham group (32.2 ± 14.5 vs 32.1 ± 13.0) (36.7 ± 12.1 vs 34.7 ± 12.7) (8.1 ± 1.7 vs 8.0 ± 1.6), respectively.

CONCLUSIONS:

NightLase is a safe, minimal invasive treatment that significantly reduced snoring compared to sham treatment.

• Authors: Valerie A Picavet, Marc Dellian, Eckard Gehrking, Alexander Sauter, Katrin Hasselbacher
• Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (Eur Arch Otorhinolaryngol) Vol. 280 Issue 1 Pg. 307-312 (Jan 2023) ISSN: 1434-4726 [Electronic] Germany
• PMID: 35867153 (Publication Type: Randomized Controlled Trial, Journal Article)
• Copyright: © 2022. The Author(s).

Topics

• Adult
• Humans
• Lasers, Solid-State (therapeutic use)
• Snoring (surgery)
• Surveys and Questionnaires
• Treatment Outcome